Aged Garlic Extract Reduces IL-6: A Double-Blind Placebo-Controlled Trial in Females with a Low Risk of Cardiovascular Disease

Table 4

Mean annual changes.

Variable	AGE		Placebo
	n = 14	SD	n = 15	SD
BMI	0.2	(1.7)	0.1	(2.4)	0.88
Systolic BP (mmol/L)	0.9	(12.8)	3.0	(13.9)	0.40
Diastolic BP (mmol/L)	7.9	(34.5)	0.0	(10.1)	0.44
Triglycerides (mmol/L)	−0.3	(39.3)	52.2	(236.7)	0.94
Cholesterol (mmol/L)	−3.9	(12.3)	−3.6	(11.8)	0.94
HDL (mmol/L)	1.1	(13.1)	1.4	(12.8)	0.38
LDL (mmol/L)	−1.6	(15.1)	4.6	(20.7)	0.15
CRP (mg/L)	−27.8	(39.4)	11.3	(65.2)	0.69
ApoB/ApoA1	0.5	(11.6)	2.3	(13.4)	0.08
Homocysteine (µmol/L)	1.1	(15.7)	12.9	(18.3)	0.62
Glucose (mmol/L)	1.9	(12.7)	−0.4	(10.2)	0.36

SD, standard deviation; Apo B/ApoA1, apolipoprotein B (mmol/L)/apolipoprotein A1 (mmol/L); BMI, body mass index (kg/m²).